Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo‐Lymphoid Morphology Mimicking Lymphoid Malignancy

A 60-year-old male presented with spontaneous hematomas and cervical adenopathy. Laboratory workup revealed hemoglobin 12.3 g/dL, platelet 56 × 109/L, and leukocyte 14.7 × 109/L. The automated cell counter (Sysmex XN) reported 9% neutrophils (1.32 × 109/L) and 86% lymphocytes (12.6 × 109/L), suggestive of a lymphoproliferative disorder. Blood smear showed atypical lymphoid cells with normal size, mature chromatin, and scant cytoplasm Figure 1 (Panel A), while numerous lysed cells were also observed (Panel B). About 10% of these cells displayed cytoplasmic vacuoles, occasionally coalescing, and 10% appeared larger with grayish cytoplasm (Panel C and D). Due to the apparent lymphocytosis, flow cytometry immunophenotyping was performed (Navios EX, Beckman-Coulter). Surprisingly, 62% of the leukocytes consisted of a CD45+low blastic population. These cells were negative for common lymphoid (CD19/CD20/CD22/CD24/cCD79a/CD3/CD5/CD8/CD10) and myeloid antigens (CD34/CD38/CD13/CD14/CD42b/CD61/CD64/CD65/CD117/cMPO), but were positive for CD4(weak)/CD56/CD123(strong)/HLA-DR(strong)/CD33 (Panel E and F). A cutaneous lesion was found on the patient's back, and bone marrow aspiration confirmed 82% of the same population with additional phenotypic markers indicative of pDC lineage (CD303+weak/CD304+/cTCL1+/BadLamp+), supporting the diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). The neurological examination was normal, and cerebrospinal involvement was inconclusive due to hemorrhagic cerebrospinal fluid samples. Furthermore, the mutational profile performed on bone marrow aspirate was consistent with BPDCN, revealing mutations in TET2, ASXL1, and NF1, as well as a subclonal NRAS mutation and deletions in the IKZF1 and ETV6 loci. BPDCN is a rare hematologic malignancy, with diverse morphological presentations. While the classic blastic morphology, often exhibiting “pearl necklace” cytoplasmic appearances and “hand-mirror-like” projections, is the most common presentation, this case displayed an unusual morphology dominated by pseudo-lymphoid cells. Although a subset of pseudo-lymphoid cells is commonly observed in BPDCN, this case was remarkable in that nearly all cells exhibited this distinctive morphology. Such atypical presentation can be deceptive, initially mimicking lymphoid malignancies. Here, the immunophenotypic profile was crucial in establishing the accurate diagnosis. R.R.-C.: analyzed date and wrote the paper. O.B., G.B., C.B., F.G.O., A.R., and F.R.: analyzed data. V.B.: coordinated the study, wrote the paper and supervised analysis. All data has been anonymized to ensure confidentiality and privacy. The authors declare no conflicts of interest.

Authors

Institutions

Publication Details

Journal
American Journal of Hematology
Published
2024-12-18
DOI
https://doi.org/10.1002/ajh.27567
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo‐Lymphoid Morphology Mimicking Lymphoid Malignancy

Victor Bobée, Anne Roggy, Florian Renosi, Catherine Boutet et al.
American Journal of Hematology
Cutaneous lymphoproliferative disorders research
article

Blastic Plasmocytoid Dendritic Cell Neoplasm With Pseudo‐Lymphoid Morphology Mimicking Lymphoid Malignancy

Victor Bobée, Anne Roggy, Florian Renosi, Catherine Boutet, Gérard Buchonnet, Francine Garnache Ottou, Romain Ravel‐Chapuis, Olivier Matray
article en

Abstract

A 60-year-old male presented with spontaneous hematomas and cervical adenopathy. Laboratory workup revealed hemoglobin 12.3 g/dL, platelet 56 × 109/L, and leukocyte 14.7 × 109/L. The automated cell counter (Sysmex XN) reported 9% neutrophils (1.32 × 109/L) and 86% lymphocytes (12.6 × 109/L), suggestive of a lymphoproliferative disorder. Blood smear showed atypical lymphoid cells with normal size, mature chromatin, and scant cytoplasm Figure 1 (Panel A), while numerous lysed cells were also observed (Panel B). About 10% of these cells displayed cytoplasmic vacuoles, occasionally coalescing, and 10% appeared larger with grayish cytoplasm (Panel C and D). Due to the apparent lymphocytosis, flow cytometry immunophenotyping was performed (Navios EX, Beckman-Coulter). Surprisingly, 62% of the leukocytes consisted of a CD45+low blastic population. These cells were negative for common lymphoid (CD19/CD20/CD22/CD24/cCD79a/CD3/CD5/CD8/CD10) and myeloid antigens (CD34/CD38/CD13/CD14/CD42b/CD61/CD64/CD65/CD117/cMPO), but were positive for CD4(weak)/CD56/CD123(strong)/HLA-DR(strong)/CD33 (Panel E and F). A cutaneous lesion was found on the patient's back, and bone marrow aspiration confirmed 82% of the same population with additional phenotypic markers indicative of pDC lineage (CD303+weak/CD304+/cTCL1+/BadLamp+), supporting the diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). The neurological examination was normal, and cerebrospinal involvement was inconclusive due to hemorrhagic cerebrospinal fluid samples. Furthermore, the mutational profile performed on bone marrow aspirate was consistent with BPDCN, revealing mutations in TET2, ASXL1, and NF1, as well as a subclonal NRAS mutation and deletions in the IKZF1 and ETV6 loci. BPDCN is a rare hematologic malignancy, with diverse morphological presentations. While the classic blastic morphology, often exhibiting “pearl necklace” cytoplasmic appearances and “hand-mirror-like” projections, is the most common presentation, this case displayed an unusual morphology dominated by pseudo-lymphoid cells. Although a subset of pseudo-lymphoid cells is commonly observed in BPDCN, this case was remarkable in that nearly all cells exhibited this distinctive morphology. Such atypical presentation can be deceptive, initially mimicking lymphoid malignancies. Here, the immunophenotypic profile was crucial in establishing the accurate diagnosis. R.R.-C.: analyzed date and wrote the paper. O.B., G.B., C.B., F.G.O., A.R., and F.R.: analyzed data. V.B.: coordinated the study, wrote the paper and supervised analysis. All data has been anonymized to ensure confidentiality and privacy. The authors declare no conflicts of interest.

American Journal of HematologyVol. 100(8)
Centre Hospitalier Universitaire de Besançon (FR), Université de Rouen Normandie (FR)
Zero hunger
Openalex Percentile: Top 51%
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.